Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Winette van der Graaf"'
Autor:
Anna M. Frezza, Vinod Ravi, Salvatore Lo Vullo, Bruno Vincenzi, Francesco Tolomeo, Tom Wei‐Wu Chen, Pawel Teterycz, Giacomo G. Baldi, Antoine Italiano, Nicolas Penel, Antonella Brunello, Florance Duffaud, Nadia Hindi, Shintaro Iwata, Alannah Smrke, Alexander Fedenko, Hans Gelderblom, Winette Van Der Graaf, Aurore Vozy, Elizabeth Connolly, Massimiliano Grassi, Robert S. Benjamin, Javier‐Martin Broto, Giovanni Grignani, Robin L. Jones, Akira Kawai, Andrzej Tysarowski, Luigi Mariani, Paolo G. Casali, Silvia Stacchiotti
Publikováno v:
Cancer Medicine, Vol 10, Iss 8, Pp 2645-2659 (2021)
Abstract Background This observational, retrospective effort across Europe, US, Australia, and Asia aimed to assess the activity of systemic therapies in EHE, an ultra‐rare sarcoma, marked by WWTR1‐CAMTA1 or YAP1‐TFE3 fusions. Methods Twenty sa
Externí odkaz:
https://doaj.org/article/56e3c27fbb994c9fa4bc5bb179921864
Autor:
Emma Lidington, Sophie E McGrath, Jillian Noble, Susannah Stanway, Amanda Lucas, Kabir Mohammed, Winette van der Graaf, Olga Husson
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-10 (2020)
Abstract Background There are a growing number of mHealth tools for breast cancer patients but a lack of scientific evidence for their effects. Recent studies have shown a mix of positive and negative impacts on users. Here we will assess the impact
Externí odkaz:
https://doaj.org/article/0393f811788448d7a8bc4d54f1133b1a
Autor:
Christian Rothermundt, Dimosthenis Andreou, Jean-Yves Blay, Thomas Brodowicz, Ingrid M.E. Desar, Palma Dileo, Hans Gelderblom, Rick Haas, Jens Jakob, Robin L. Jones, Ian Judson, Wolfgang G. Kunz, Berndadette Liegl-Atzwanger, Lars H. Lindner, Christina Messiou, Aisha B. Miah, Peter Reichardt, Joanna Szkandera, Winette T.A. van der Graaf, Winan J. van Houdt, Eva Wardelmann, Silvia Hofer, Thomas Barth, Sebastian Bauer, Veronika Blum, Beata Bode, Sylvie Bonvalot, Judith Bovee, Petra Braam, Jean Martin Broto, Angelo Dei Tos, Dominik Denschlag, Ingrid Desar, Antonia Digklia, Uta Dirksen, Thomas Douchy, Florence Duffaud, Mikael Eriksson, Stefan Fröhling, Alessandro Gronchi, Jenrik Hardes, Wolfgang Hartmann, Peter Hohenberger, Daphne Hompes, Paul Huang, Antoine Italiano, Robin Jones, Günter Köhler, Attila Kollàr, Fatime Krasniqi, Stijn Krol, Wolfgang Kunz, Franel Le Grange, Cécile Le Pechoux, Alexandre LeCesne, Andreas Leithner, Bernadette Liegl-Atzwanger, Lars Lindner, Gunhild Mechtersheimer, Aisha Miah, Daniel Pink, Cleo Romagosa, Piotr Rutkowski, Akmel Safwat, Claudia Sangalli, Khin Thway, Per-Ulf Tunn, Winette Van der Graaf, Winan Van Houdt, Ralph Zachariah, Sander Botter, Thomas Cerny
Publikováno v:
European Journal of Cancer, 180, pp. 158-179
European Journal of Cancer, 180, 158-179
European Journal of Cancer, 180, 158-179
Owing to the rarity and heterogeneity in biology and presentation, there are multiple areas in the diagnosis, treatment and follow-up of soft tissue sarcoma (STS), with no, low-level or conflicting evidence.During the first Consensus Conference on th
Autor:
Marie Morfouace, Peter Horak, Simon Kreutzfeldt, Aleksandra Stevovic, Teresa de Rojas, Evgeniya Denisova, Barbara Hutter, Francisco Bautista, Júlio Oliveira, Anne-Sophie Defachelles, Jeff White, Bernd Kasper, Matthias Preusser, Vassilis Golfinopoulos, Stefan Pfister, Winette Van der Graaf, Eva Wardelmann, Patrick Shenjere, Stefan Fröhling, Martin G. McCabe
Publikováno v:
European Journal of Cancer, 178, 216-226. Elsevier Ltd.
Background: Adolescent and young adult (AYA) patients with cancer are poorly recruited to molecularly targeted trials and have not witnessed the advances in cancer treatment and survival seen in other age groups. We report here a pan-European proof-o
Autor:
Winette Van der Graaf, Denis Lacombe
Publikováno v:
European journal of cancer (Oxford, England : 1990). 178
Autor:
Ibtissam Acem, Cornelis Verhoef, Anja J. Rueten-Budde, Dirk J. Grünhagen, Winan J. van Houdt, Michiel A.J. van de Sande, Will Aston, Han Bonenkamp, Ingrid M.E. Desar, Peter C. Ferguson, Marta Fiocco, Hans Gelderblom, Robert J. van Ginkel, Winette van der Graaf, Anthony M. Griffin, Rick L. Haas, Jos A. van der Hage, Andrew J. Hayes, Lee M. Jeys, Johnny Keller, Minna K. Laitinen, Andreas Leithner, Katja Maretty-Kongstad, Toshifumi Ozaki, Rob Pollock, Veroniek M. van Praag, Myles J. Smith, Maria A. Smolle, Emelie Styring, Joanna Szkandera, Kazuhiro Tanaka, Per-Ulf Tunn, Madeleine Willegger, Reinard Windhager, Jay S. Wunder, Olga Zaikova
Publikováno v:
European Journal of Cancer. 162:247-249
Publikováno v:
Pediatric Blood & Cancer. 69
Desmoid-type fibromatosis (DTF) is a rare locally aggressive soft tissue neoplasm, which occurs in children and adults, with a peak incidence in young adults. For the majority of the patients, DTF is a chronic and symptomatic disease, which affects h
Autor:
Anne-Rose Schut, Emma Lidington, Milea Timbergen, Eugenie Younger, Winette van der Graaf, Winan van Houdt, Johannes Bonenkamp, Robin Jones, Dirk Grünhagen, Stefan Sleijfer, Cornelis Verhoef, Spyridon Gennatas, Olga Husson
Publikováno v:
European Journal of Surgical Oncology. 49:e56
Autor:
Marie Morfouace, Peter Horak, Simon Kreutzfeldt, Patrick Shenjere, Eva Wardelmann, Evgeniya Denisova, Aleksandra Stevovic, Francisco J. Bautista, Julio Oliveira, Winette van der Graaf, Stefan Fröhling, Martin G. McCabe
Publikováno v:
Cancer Research. 82:2005-2005
Introduction: Yearly, around 45,000 new diagnoses of cancer in the adolescent and young adult (AYA) population are made in Europe, with sarcoma and brain tumors being some of the most prevalent tumor types.Despite great progress being made in underst
Autor:
Saoirse O, Dolly, Eleftheria, Kalaitzaki, Martina, Puglisi, Sarah, Stimpson, Janet, Hanwell, Sonia Serrano, Fandos, Sarah, Stapleton, Thushara, Ansari, Clare, Peckitt, Stan, Kaye, Juanita, Lopez, Timothy A, Yap, Winette, van der Graaf, Johann, de Bono, Udai, Banerji
Publikováno v:
Cancer
BACKGROUND To better inform clinical practice, this study was aimed at capturing patients' motivations for enrolling in phase 1 trials and at quantifying their expectations of the benefits, risks, and commitment associated with clinical trials and th